UC-961

cirmtuzumab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UC-961, covering 2020-08-13 to 2020-08-13. Get the full timeline:

Most recent: Clinical Trial Update: UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1]